A detailed history of Swiss National Bank transactions in Maxcyte, Inc. stock. As of the latest transaction made, Swiss National Bank holds 184,400 shares of MXCT stock, worth $636,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184,400
Previous 184,400 -0.0%
Holding current value
$636,180
Previous $722,000 0.69%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$3.63 - $5.0 $39,567 - $54,500
10,900 Added 6.28%
184,400 $722,000
Q4 2023

Feb 06, 2024

SELL
$2.6 - $5.24 $43,940 - $88,556
-16,900 Reduced 8.88%
173,500 $815,000
Q2 2023

Aug 09, 2023

BUY
$3.69 - $5.35 $133,578 - $193,670
36,200 Added 23.48%
190,400 $873,000
Q1 2023

May 10, 2023

SELL
$4.03 - $5.89 $71,734 - $104,842
-17,800 Reduced 10.35%
154,200 $763,000
Q4 2022

Feb 08, 2023

BUY
$4.92 - $7.4 $22,632 - $34,040
4,600 Added 2.75%
172,000 $939,000
Q2 2022

Aug 09, 2022

BUY
$3.59 - $6.81 $44,516 - $84,444
12,400 Added 8.0%
167,400 $792,000
Q1 2022

May 09, 2022

BUY
$5.26 - $10.84 $59,964 - $123,576
11,400 Added 7.94%
155,000 $1.08 Million
Q4 2021

Feb 08, 2022

BUY
$8.87 - $12.94 $1.27 Million - $1.86 Million
143,600 New
143,600 $1.46 Million

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $351M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.